|
NAMS NewAmsterdam Pharma Company NV 1936258 |
| Balance Sheet |
|
Current Assets
|
$658,044,000.00 |
|
Assets
|
$471,098,000.00 |
|
Current Liabilities
|
$67,421,000.00 |
|
Liabilities
|
$67,421,000.00 |
|
Equity
|
$665,222,000.00 |
|
Shares Out
|
116641656.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-30,604,000.00 |
|
Investing Cash Flow
|
$-11,509,000.00 |
| Market Analysis |
Market Cap
|
$3,319,621,529.76 |
|
Price
|
$27.38 |
|
BVPS
|
5.70 |
|
PB
|
4.99 |
|
EPS
|
-0.40 |
|
PS
|
337.36 |
|
FCF
|
$-30,642,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:20 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:15 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAMS documents filed with the SEC.
NAMS Filings
Clear
